http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013166468-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d26aa6b4d13b06d2ea3093b7548b9ec5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 |
| filingDate | 2013-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e7e607e4aa680df38ded8ea03b8f1f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de9b909c23580b9b30d1d1ec25bd93f9 |
| publicationDate | 2013-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2013166468-A1 |
| titleOfInvention | Compositions and methods for treating neurodegenerative diseases |
| abstract | Huperzine A analog compounds having acetylcholinesterase inhibitor activity are described. The huperzine analogs are used in the treatment of neurodegenerative diseases. Various compositions and methods include an NMDA receptor antagonist and either a mitochondrial protectant or anti-inflammatory agent. The acetylcholinesterase inhibitor may be specific to the G4 isoform of acetylcholinesterase. Methods of treating neurodegenerative diseases by administering a composition having a therapeutically effective amount of one of the acetycholinesterate compounds are described. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108653290-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108653290-B |
| priorityDate | 2012-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 509.